![A SAS-based solution to evaluate study design efficiency of phase I pediatric oncology trials via discrete event simulation - ScienceDirect A SAS-based solution to evaluate study design efficiency of phase I pediatric oncology trials via discrete event simulation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169260708000035-gr1.jpg)
A SAS-based solution to evaluate study design efficiency of phase I pediatric oncology trials via discrete event simulation - ScienceDirect
![Phase 1 Study of No-Carrier Added <sup xmlns="">177</sup>Lu-DOTATATE (SNU-KB-01) in Patients with Somatostatin Receptor–Positive Neuroendocrine Tumors: The First Clinical Trial of Peptide Receptor Radionuclide Therapy in Korea Phase 1 Study of No-Carrier Added <sup xmlns="">177</sup>Lu-DOTATATE (SNU-KB-01) in Patients with Somatostatin Receptor–Positive Neuroendocrine Tumors: The First Clinical Trial of Peptide Receptor Radionuclide Therapy in Korea](https://www.e-crt.org/upload//thumbnails/crt-2021-1022f1.jpg)
Phase 1 Study of No-Carrier Added <sup xmlns="">177</sup>Lu-DOTATATE (SNU-KB-01) in Patients with Somatostatin Receptor–Positive Neuroendocrine Tumors: The First Clinical Trial of Peptide Receptor Radionuclide Therapy in Korea
![Tri-Arc UKDEC106242 U-Design Configurable 6-Step Forward Descent Incline Rolling Ladder with 24" Wide Grip Strut Tread: Amazon.com: Tools & Home Improvement Tri-Arc UKDEC106242 U-Design Configurable 6-Step Forward Descent Incline Rolling Ladder with 24" Wide Grip Strut Tread: Amazon.com: Tools & Home Improvement](https://m.media-amazon.com/images/I/810Q+N+MhkL._AC_UF350,350_QL80_.jpg)
Tri-Arc UKDEC106242 U-Design Configurable 6-Step Forward Descent Incline Rolling Ladder with 24" Wide Grip Strut Tread: Amazon.com: Tools & Home Improvement
![Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials - Annals of Oncology Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/e0af42fc-dfe4-4755-b08e-e843d61c7742/gr1.jpg)
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials - Annals of Oncology
![HOMACER 6 ft./72 in. Black Rustic Double Track Bypass U-Shape Sliding Barn Door Hardware Kit - Diamond Design Roller LX4TGH072C - The Home Depot HOMACER 6 ft./72 in. Black Rustic Double Track Bypass U-Shape Sliding Barn Door Hardware Kit - Diamond Design Roller LX4TGH072C - The Home Depot](https://images.thdstatic.com/productImages/a55f2525-244f-4093-9f27-a8eac8c42866/svn/black-homacer-barn-door-hardware-dz4tgh072c-64_300.jpg)
HOMACER 6 ft./72 in. Black Rustic Double Track Bypass U-Shape Sliding Barn Door Hardware Kit - Diamond Design Roller LX4TGH072C - The Home Depot
![Bertrand Delsuc on Twitter: "Straathof/UCL - clinical trial using a rolling 6 design 14/14=100% manuf success rate product characteristics https://t.co/CamF3tdlCU" / Twitter Bertrand Delsuc on Twitter: "Straathof/UCL - clinical trial using a rolling 6 design 14/14=100% manuf success rate product characteristics https://t.co/CamF3tdlCU" / Twitter](https://pbs.twimg.com/media/Dzbock-W0AAdfeK.jpg)
Bertrand Delsuc on Twitter: "Straathof/UCL - clinical trial using a rolling 6 design 14/14=100% manuf success rate product characteristics https://t.co/CamF3tdlCU" / Twitter
![A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5801-3/MediaObjects/12885_2019_5801_Fig2_HTML.png)
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text
![A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5801-3/MediaObjects/12885_2019_5801_Fig1_HTML.png)
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text
![Model-Assisted Designs for Early-Phase Clinical Trials: Simplicity Meets Superiority | JCO Precision Oncology Model-Assisted Designs for Early-Phase Clinical Trials: Simplicity Meets Superiority | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2019/po.2019.3/po.19.00032/20191023/images/large/po.19.00032t1.jpeg)
Model-Assisted Designs for Early-Phase Clinical Trials: Simplicity Meets Superiority | JCO Precision Oncology
![Practical considerations for the implementation of adaptive designs for oncology Phase I dose-finding trials | Future Drug Discovery Practical considerations for the implementation of adaptive designs for oncology Phase I dose-finding trials | Future Drug Discovery](https://www.future-science.com/cms/10.4155/fdd-2019-0021/asset/images/medium/figure1.gif)